Lexicon Pharmaceuticals
LXRX
#6594
Rank
C$0.96 B
Marketcap
C$2.28
Share price
5.13%
Change (1 day)
248.88%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$0.12 M-98.97%
2025C$12.43 M-38.43%
2024C$20.19 M111.04%
2023C$9.57 M315.88%
2022C$2.3 M-91.22%
2021C$26.2 M1.63%
2020C$25.78 M21.18%
2019C$21.27 M-6.95%
2018C$22.86 M-27.5%
2017C$31.53 M18.35%
2016C$26.64 M59.83%
2015C$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
C$5.59 MC$58.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$12.26 MC$21.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$3.38 MC$50.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$3.71 MC$9.28 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$5.84 MC$14.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.52 MC$8.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/AC$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.4 MC$14.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AC$0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA